Literature DB >> 22958626

Pulmonary hypertension diagnosed by echocardiography during idiopathic myelofibrosis. A case report and a brief review of the literature.

Claudio Perrone1, Roberto Cartolari, Beatrice Lupi, Sergio Morelli.   

Abstract

Idiopathic myelofibrosis is a rare chronic myeloproliferative disease leading to extramedullary hematopoiesis (myeloid metaplasia) with splenomegaly. The liver and less frequently other organs including the lung can be involved, therefore portal hypertension is relatively common. Pulmonary hypertension (PH) is only occasionally reported, although recent studies have suggested an association between PH and myeloproliferative disorders.We present a case of PH diagnosis by echocardiography in a patient affected by idiopathic myelofibrosis with portal hypertension.

Entities:  

Year:  2010        PMID: 22958626      PMCID: PMC3436631          DOI: 10.1186/2049-6958-5-4-267

Source DB:  PubMed          Journal:  Multidiscip Respir Med        ISSN: 1828-695X


  18 in total

1.  High levels of circulating CD34 cells, dacrocytes, clonal hematopoiesis, and JAK2 mutation differentiate myelofibrosis with myeloid metaplasia from secondary myelofibrosis associated with pulmonary hypertension.

Authors:  Uday Popat; Adaani Frost; Enli Liu; Yongli Guan; April Durette; Vishnu Reddy; Josef T Prchal
Journal:  Blood       Date:  2006-01-17       Impact factor: 22.113

2.  Auto-immunity in primary myelofibrosis.

Authors:  J M Lang; F Oberling; S Mayer; E Heid
Journal:  Biomedicine       Date:  1976-02-10

Review 3.  Myelofibrosis with myeloid metaplasia: disease overview and non-transplant treatment options.

Authors:  Ruben A Mesa; Giovanni Barosi; Francisco Cervantes; John T Reilly; Ayalew Tefferi
Journal:  Best Pract Res Clin Haematol       Date:  2006       Impact factor: 3.020

Review 4.  Myelofibrosis with myeloid metaplasia.

Authors:  A Tefferi
Journal:  N Engl J Med       Date:  2000-04-27       Impact factor: 91.245

Review 5.  Primary pulmonary hypertension.

Authors:  S P Gaine; L J Rubin
Journal:  Lancet       Date:  1998-08-29       Impact factor: 79.321

6.  Pulmonary hypertension associated with myeloproliferative disorders: a retrospective study of ten cases.

Authors:  P Guilpain; D Montani; G Damaj; L Achouh; F Lefrère; J Le Pavec; A Marfaing-Koka; P Dartevelle; G Simonneau; M Humbert; O Hermine
Journal:  Respiration       Date:  2007-12-21       Impact factor: 3.580

7.  Pulmonary fibrosis and sea-blue histiocyte infiltration in a patient with primary myelofibrosis.

Authors:  K Yamauchi; K Shimamura
Journal:  Eur Respir J       Date:  1995-09       Impact factor: 16.671

8.  Severe pulmonary hypertension associated with macronodular (postnecrotic) cirrhosis and autoimmune phenomena.

Authors:  E B Morrison; F A Gaffney; E H Eigenbrodt; R C Reynolds; L M Buja
Journal:  Am J Med       Date:  1980-10       Impact factor: 4.965

Review 9.  Pulmonary hypertension in systemic lupus erythematosus: report of four cases and review of the literature.

Authors:  H D Perez; N Kramer
Journal:  Semin Arthritis Rheum       Date:  1981-08       Impact factor: 5.532

Review 10.  Association between primary pulmonary hypertension and portal hypertension: analysis of its pathophysiology and clinical, laboratory and hemodynamic manifestations.

Authors:  B D Robalino; D S Moodie
Journal:  J Am Coll Cardiol       Date:  1991-02       Impact factor: 24.094

View more
  1 in total

1.  Prevalence and Effect on Survival of Pulmonary Hypertension in Myelofibrosis.

Authors:  Matthew Austin; Peter J Quesenberry; Corey E Ventetuolo; Olin Liang; John L Reagan
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2019-05-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.